Bibliography
- Surface LE , ThorntonSR, BoyerLA: Polycomb group proteins set the stage for early lineage commitment.Cell Stem Cell7 , 288–298 (2010).
- Aoki R , ChibaT, MiyagiSet al.: The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.J. Hepatol.52 , 854–863 (2010).
- Varambally S , DhanasekaranSM, ZhouMet al.: The polycomb group protein EZH2 is involved in progression of prostate cancer.Nature419 , 624–629 (2002).
- Crea F , MathewsLA, FarrarWL, HurtEM: Targeting prostate cancer stem cells.Anticancer Agents Med. Chem.9 , 1105–1113 (2009).
- Suva ML , RiggiN, JaniszewskaMet al.: EZH2 is essential for glioblastoma cancer stem cell maintenance.Cancer Res.69 , 9211–9218 (2009).
- Orzan F , PellegattaS, PolianiLet al.: Enhancer of zeste 2 (EzH2) is up-regulated in malignant gliomas and in glioma stem-like cells.Neuropathol. Appl. Neurobiol. DOI: doi: 10.1111/j.1365–2990.2010.01132 (2010) (Epub ahead of print).
- Crea F , HurtEM, FarrarWL: Clinical significance of Polycomb gene expression in brain tumors.Mol. Cancer9 , 265 (2010).
- Wang H , OuyangY, SomersWG, ChiaW, LuB: Polo inhibits progenitor self-renewal and regulates Numb asymmetry by phosphorylating Pon.Nature449 , 96–100 (2007).
- Yu J , YuJ, RhodesDRet al.: A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.Cancer Res.67 , 10657–10663 (2007).
- Berezovska OP , GlinskiiAB, YangZ, LiXM, HoffmanRM, GlinskyGV: Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.Cell Cycle5 , 1886–1901 (2006).
- Hurt EM , FarrarWL: Cancer stem cells: the seeds of metastasis?Mol. Interv.8 , 140–142 (2008).
- Yasuda H , SoejimaK, WatanabeHet al.: Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors.Int. J. Oncol.37 , 1537–1546 (2010).
- Hurt EM , KawasakiBT, KlarmannGJ, ThomasSB, FarrarWL: CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.Br. J. Cancer98 , 756–765 (2008).
- Dick JE : Looking ahead in cancer stem cell research.Nat. Biotechnol.27 , 44–46 (2009).
- Cao Q , YuJ, DhanasekaranSMet al.: Repression of E-cadherin by the polycomb group protein EZH2 in cancer.Oncogene27 , 7274–7284 (2008).
- Mathews LA , HurtEM, ZhangX, FarrarWL: Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.Mol. Cancer9 , 267 (2010).